Accelitech embarks on a proton cancer therapy project

Accelitech LLC, the leader in the development and full-cycle management of technology-driven cancer treatment programs, is pleased to announce its inaugural proton therapy project. The treatment center project, now under development, is the latest in Accelitech's ongoing effort to bring leading treatment technologies to more patients through joint-venture partnerships with physicians and hospitals.

Proton therapy is a cutting-edge cancer treatment that targets tumors with a beam of protons traveling at two-thirds the speed of light. By delivering doses with pinpoint precision, proton therapy is painless, non-invasive and highly effective in treating tumors while minimizing damage to surrounding healthy tissue.

Due to the high cost and large scope of developing a proton therapy center, there are only a handful of places in the U.S. where patients can receive the treatment. With recent lower cost options entering the market, Accelitech hopes to change that by using its existing model to target several proton therapy locations over the next two years.

"The technology may be new, but our model for success remains the same," says Kerwin Brandt, President and CEO of Accelitech. "Proton therapy is the next generation of cancer treatment, and this project is an exciting opportunity to apply our proven, full-cycle management process to making this state-of-the-art technology available to patients on a broader scale."